What is Vir Biotechnology, Inc.'s AOCI?

Vir Biotechnology, Inc. (VIR) reported AOCI of -$3.48M in Q1 2026.

How has Vir Biotechnology, Inc.'s AOCI changed year-over-year?

Vir Biotechnology, Inc.'s AOCI decreased by 76.4% year-over-year, from -$1.98M to -$3.48M.

What is the long-term trend for Vir Biotechnology, Inc.'s AOCI?

Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s AOCI has grown at a 10.0% compound annual growth rate (CAGR), from -$1.28M to -$2.06M.

Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.

Vir Biotechnology, Inc. VIR AOCI

AOCI at other companies

AmgenAMGN

-$190M+17.7%

Regeneron PharmaceuticalsREGN

$11.9M-59.1%

Gilead SciencesGILD

$78M-15.2%

Viridian Therapeutics, Inc.VRDN

-$558K-328%

Iovance Biotherapeutics, Inc.IOVA

$12.65M+101%

Nuvation BioNUVB

-$1.68M-408%

Other financials

Income statement

See full

Revenue-$29.0K-101%

Gross profit$1.2M-60.2%

Operating income-$132.3M+5.2%

Net income-$125.7M-3.9%

EPS (diluted)-$0.85+3.4%

Balance sheet

See full

Cash & equivalents$283.0M-23.1%

Total debt$95.6M-0.5%

Total equity$812.8M-22.1%

Total assets$1.0B-21.6%

Cash flow

See full

Operating cash flow-$132.4M-69.5%

CapEx$390.0K-76.1%

Free cash flow-$132.8M-66.5%

Valuation

See full

Market cap$1.68B+61.1%

Profitability

See full

Gross margin96.1%-2.7pp

Operating margin-720.8%-313pp

Net margin-676%-291pp

FCF margin-686.5%-273pp

Returns & leverage

See full

Return on equity-47.7%+3.6pp

Debt / equity0.1×0.0×

Current ratio7.1×+0.3×

Where this comes from

Reported directly by Vir Biotechnology, Inc. in its filing.

Tagged under the XBRL concept us-gaap:AccumulatedOtherComprehensiveIncomeLossNetOfTax.

The official record: Vir Biotechnology, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vir Biotechnology, Inc.'s aoci.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vir Biotechnology, Inc.'s AOCI?: Vir Biotechnology, Inc. (VIR) reported AOCI of -$3.48M in Q1 2026.
How has Vir Biotechnology, Inc.'s AOCI changed year-over-year?: Vir Biotechnology, Inc.'s AOCI decreased by 76.4% year-over-year, from -$1.98M to -$3.48M.
What is the long-term trend for Vir Biotechnology, Inc.'s AOCI?: Over 5 years (2020 to 2025), Vir Biotechnology, Inc.'s AOCI has grown at a 10.0% compound annual growth rate (CAGR), from -$1.28M to -$2.06M.
What does AOCI mean?: Accumulated gains and losses bypassing the income statement — unrealized investment gains/losses, currency translation, pension adjustments, and hedge results.